Srinivas Akkaraju

Srinivas Akkaraju is a declared insider at 8 companies (board member); the most frequent names are Alumis Inc., Scholar Rock Holding Corp and Kalaris Therapeutics, Inc. In total, 66 filings cover trades dated from 27 May 2021 to 8 September 2026.

On the open market, the record shows 35 purchases worth €128.2M and 3 sales worth €13.6M. The amount is not disclosed for 1 filing. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 16 share grants and 4 option exercises. Since January 2026: 7 purchases and 2 sales on the market.

In size, the median ticket on the buying side is €1.1M. Measured against the company's value, the median purchase equals 0.28% of market capitalisation, across 4 purchases where it is known. 16 out of 34 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. For 25 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 56% of cases, with a median move of +6.8%. This is a record of the past, not a forecast.

The latest filing, published on 9 September 2026, reports an open-market purchase of €2.1M in Alumis Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.